معرفی
Thuy Dung Nguyen serves as a Postdoctoral Researcher (mapped to Research Fellow academic rank) at Karolinska Institutet's Department of Medical Epidemiology and Biostatistics within Lu Yi's Precision Psychiatry research group (2024-2026). Her work integrates Scandinavian national register data with advanced genetic epidemiological methods to dissect depression heterogeneity.
Her academic credentials include:
- PhD in Medical Epidemiology and Biostatistics, Karolinska Institutet (2024)
- Master of Medical Science (120 Credits), Karolinska Institutet (2018)
- Master of Public Health in Epidemiology, Karolinska Institutet (2018)
- Bachelor of Public Health (Epidemiology/Biostatistics major), Hanoi University of Public Health (2013)
Dr. Nguyen's research investigates the genetic architecture of major depressive disorder (MDD) subtypes through genome-wide association studies and sibling-based register analyses. She pioneers work on depression's mood-psychotic spectrum connections and Scandinavian burden epidemiology while exploring physical activity/sedentary behavior impacts on mental health. Her methodological toolkit includes Mendelian randomization for drug repurposing studies and causal inference in psychiatric genetics.
Publication analysis reveals three dominant research thrusts: (1) Genetic dissection of MDD heterogeneity and subtypes (70% of recent work), (2) Scandinavian register-based depression epidemiology (20%), and (3) Physical activity/sedentary behavior interactions with mental health (10%). Her 2025-2023 output emphasizes cross-disorder genetic analyses while earlier work established physical activity's protective role against depression.
No scientific awards are documented in available sources.
Current advising activities and grant leadership are not publicly specified, though she contributes to large collaborative projects like the Swedish National March Cohort. Her role focuses on data analysis within Lu Yi's team rather than independent mentorship.
She operates within Karolinska Institutet's Precision Psychiatry group which develops stratified treatment approaches for depression through genetic, epidemiological, and clinical data integration. The team leverages Scandinavia's unique population registers to identify depression endophenotypes for targeted interventions.
